Exercise or conversion by Marshall Keith W of 10000 shares of Prometheus Biosciences subject to Rule 16b-3

Slightly above 67% of Prometheus Biosciences' investor base is looking to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are alarmed regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investing sentiment can be driven by a variety of factors including economic data, Prometheus Biosciences' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Prometheus Biosciences In officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Prometheus insider trading alert for exercise of common stock by Marshall Keith W, Chief Financial Officer, on 8th of March 2023. This event was filed by Prometheus Biosciences In with SEC on 2023-03-08. Statement of changes in beneficial ownership - SEC Form 4

Prometheus Biosciences Fundamental Analysis

We analyze Prometheus Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prometheus Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prometheus Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Prometheus Biosciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Prometheus Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prometheus Biosciences stock to make a market-neutral strategy. Peer analysis of Prometheus Biosciences could also be used in its relative valuation, which is a method of valuing Prometheus Biosciences by comparing valuation metrics with similar companies.

Peers

Prometheus Biosciences Related Equities

PLRXPliant Therapeutics   7.59   
0%
54.0%
APLSApellis Pharmaceuticals   5.71   
0%
40.0%
TERNTerns Pharmaceuticals   5.12   
0%
36.0%
VKTXViking Therapeutics   3.98   
0%
28.0%
MDGLMadrigal Pharmaceuticals   3.29   
0%
23.0%
AMLXAmylyx Pharmaceuticals   3.11   
0%
22.0%
IMVTImmunovant   2.42   
0%
17.0%
ETNB89bio   1.97   
0%
14.0%
STOKStoke Therapeutics   1.78   
0%
12.0%
ROIVRoivant Sciences   1.77   
0%
12.0%
DAWNDay One   1.35   
0%
9.0%
ACLXArcellx   1.32   
0%
9.0%
AKROAkero Therapeutics   0.52   
0%
3.0%
KRYSKrystal Biotech   14.04   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Prometheus Stock

If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk